Melanoma drug shrinks brain metastases in phase I/II study
( European Society for Medical Oncology ) A new drug being developed to treat potentially deadly melanoma skin cancers has shown a promising ability to shrink secondary tumors, known as metastases, in the brain in patients with advanced forms of the disease, Australian researchers report.
Read more on EurekAlert!
Men remain critical after drug shed blaze
TWO men have suffered serious burns from a drug shed fire in Sydney’s southwest overnight.
Read more on News.com.au
FDA warns Utah firm, others marketing miracle cures
The Food and Drug Administration warned eight companies on Thursday to stop marketing miracle cures that claim to treat…
Read more on Deseret News